Scott Gray-Owen, Ph.D., and Dr. Trevor Moraes, Ph.D., developing vaccines for humans and food production animals. Their combined expertise in antigen selection, design and testing provided a ...
Several observations point toward the possibility of a vaccine development strategy ... of most of these surface proteins has made antigen selection problematic. Obstacles to the development ...
Selection of 19 individual researchers among ... Cheever and colleagues establish a definition of 'ideal' antitumor vaccine antigens based on weighted criteria, including: evidence of antitumor ...
Nov. 18, 2024 — A new nasal whooping cough vaccine showed an ability to prevent both infection and transmission of the disease in mice. Current vaccines offer treatment but fail to halt ...
“Developing a new vaccine was based on foundational research that the team of researchers was already doing. Dr. Schryvers’ work on antigen design and reengineering, essential to vaccine ...
Louis, and colleagues developed a neoantigen DNA vaccine platform capable of presenting human leukocyte antigen class I and II epitopes. Tumor/normal exome sequencing and tumor RNA sequencing were ...
AI-Immunology™ can select ERV antigens for precision therapeutic cancer vaccines, offering therapeutic options for multiple specific cancer types and potentially enabling treatment for patients ...